Literature DB >> 11381566

Time-dependent oral absorption models.

K Higaki1, S Yamashita, G L Amidon.   

Abstract

The plasma concentration-time profiles following oral administration of drugs are often irregular and cannot be interpreted easily with conventional models based on first- or zero-order absorption kinetics and lag time. Six new models were developed using a time-dependent absorption rate coefficient, ka(t), wherein the time dependency was varied to account for the dynamic processes such as changes in fluid absorption or secretion, in absorption surface area, and in motility with time, in the gastrointestinal tract. In the present study, the plasma concentration profiles of propranolol obtained in human subjects following oral dosing were analyzed using the newly derived models based on mass balance and compared with the conventional models. Nonlinear regression analysis indicated that the conventional compartment model including lag time (CLAG model) could not predict the rapid initial increase in plasma concentration after dosing and the predicted Cmax values were much lower than that observed. On the other hand, all models with the time-dependent absorption rate coefficient, ka(t), were superior to the CLAG model in predicting plasma concentration profiles. Based on Akaike's Information Criterion (AIC), the fluid absorption model without lag time (FA model) exhibited the best overall fit to the data. The two-phase model including lag time, TPLAG model was also found to be a good model judging from the values of sum of squares. This model also described the irregular profiles of plasma concentration with time and frequently predicted Cmax values satisfactorily. A comparison of the absorption rate profiles also suggested that the TPLAG model is better at prediction of irregular absorption kinetics than the FA model. In conclusion, the incorporation of a time-dependent absorption rate coefficient ka(t) allows the prediction of nonlinear absorption characteristics in a more reliable manner.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11381566     DOI: 10.1023/a:1011573831444

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  11 in total

1.  Absorption behavior of orally administered drugs in rats treated with propantheline.

Authors:  S Haruta; N Iwasaki; K Ogawara; K Higaki; T Kimura
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

2.  Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.

Authors:  T Sawamoto; S Haruta; Y Kurosaki; K Higaki; T Kimura
Journal:  J Pharm Pharmacol       Date:  1997-04       Impact factor: 3.765

3.  The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.

Authors:  R L Oberle; G L Amidon
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

4.  Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi-fraction absorption models.

Authors:  K Murata; K Noda; K Kohno; M Samejima
Journal:  J Pharm Sci       Date:  1987-02       Impact factor: 3.534

5.  Discontinuous absorption processes in pharmacokinetic models.

Authors:  R Süverkrüp
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

6.  Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH.

Authors:  P Langguth; K M Lee; H Spahn-Langguth; G L Amidon
Journal:  Biopharm Drug Dispos       Date:  1994-12       Impact factor: 1.627

7.  Use of metzler's NONLIN program for fitting discontinuous absorption profiles.

Authors:  J J Zimmerman
Journal:  J Pharm Sci       Date:  1983-02       Impact factor: 3.534

8.  Kinetics of acetaminophen absorption and gastric emptying in man.

Authors:  J A Clements; R C Heading; W S Nimmo; L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

9.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

10.  The effect of dosage release formulations on the pharmacokinetics of propranolol stereoisomers in humans.

Authors:  B E Bleske; L S Welage; S Rose; G L Amidon; M J Shea
Journal:  J Clin Pharmacol       Date:  1995-04       Impact factor: 3.126

View more
  13 in total

1.  The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Authors:  Chantal Csajka; David Drover; Davide Verotta
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

2.  Collapsing mechanistic models: an application to dose selection for proof of concept of a selective irreversible antagonist.

Authors:  Matthew M Hutmacher; Debu Mukherjee; Kenneth G Kowalski; David C Jordan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

Review 3.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

4.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

5.  Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.

Authors:  Josef A Vogt; Christian Denzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-02       Impact factor: 2.745

6.  Time-dependent clearance of mycophenolic acid in renal transplant recipients.

Authors:  Reinier M van Hest; Teun van Gelder; René Bouw; Timothy Goggin; Robert Gordon; Richard D Mamelok; Ron A Mathot
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

7.  Application of the convection-dispersion equation to modelling oral drug absorption.

Authors:  Jan I Freijer; Teun M Post; Bart A Ploeger; Joost DeJongh; Meindert Danhof
Journal:  Bull Math Biol       Date:  2006-10-06       Impact factor: 1.758

8.  Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.

Authors:  Peter L Bonate; Simon Floret; Craig Bentzen
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

9.  Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Authors:  Yukiko Metsugi; Yoshihiro Miyaji; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

10.  Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.

Authors:  Reinier M van Hest; Teun van Gelder; Arnold G Vulto; Leslie M Shaw; Ron A A Mathot
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.